Cargando…

Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination

Tumor specific antigens (TSA) provide an opportunity to mobilize therapeutic immune responses against cancer. To evade such responses, tumor development in immunocompetent hosts is accompanied by acquisition of both active and passive mechanisms of immune suppression, including recruitment of CD4+Fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schreiber, Taylor H., Wolf, Dietlinde, Bodero, Maria, Podack, Eckhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429568/ https://www.ncbi.nlm.nih.gov/pubmed/22934256 http://dx.doi.org/10.4161/onci.20298

Ejemplares similares

In-vitro inhibition of IFNγ(+) iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function
por: Daniel, Volker, et al.
Publicado: (2012)

Cholesterol suppresses human iTreg differentiation and nTreg function through mitochondria-related mechanisms
por: Zhang, Huanzhi, et al.
Publicado: (2023)

Efficient induction of CD25(- )iTreg by co-immunization requires strongly antigenic epitopes for T cells
por: Geng, Shuang, et al.
Publicado: (2011)

Altered expression and editing of miRNA-100 regulates iTreg differentiation
por: Negi, Vinny, et al.
Publicado: (2015)

TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity
por: Riquelme, Paloma, et al.
Publicado: (2018)

Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
por: Hui, Zhenzhen, et al.
Publicado: (2021)

Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways
por: Lu, Yunjie, et al.
Publicado: (2014)

P38 MAP Kinase Signaling Is Required for the Conversion of CD4+CD25− T Cells into iTreg
por: Huber, Samuel, et al.
Publicado: (2008)

CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro
por: Pilat, Nina, et al.
Publicado: (2018)

Combined Treatment With TGF-β1, Retinoic Acid, and Lactoferrin Robustly Generate Inducible Tregs (iTregs) Against High Affinity Ligand
por: Jang, Young-Saeng, et al.
Publicado: (2023)

ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation
por: Tian, Miaomiao, et al.
Publicado: (2021)

IL-1 signaling modulates STAT activation to antagonize retinoic acid signaling and control Th17–iTreg balance
por: Basu, Rajatava, et al.
Publicado: (2015)

Arkadia-SKI/SnoN signaling differentially regulates TGF-β–induced iTreg and Th17 cell differentiation
por: Xu, Hao, et al.
Publicado: (2021)

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity
por: Xia, Meng, et al.
Publicado: (2017)

CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39
por: Zhang, Xiao, et al.
Publicado: (2019)

The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4(+) T cells resembling iTreg
por: Tauber, Peter A., et al.
Publicado: (2023)

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer
por: Cheng, Yifei, et al.
Publicado: (2023)

ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs
por: De Souza, Adriano Luís Soares, et al.
Publicado: (2018)

Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives
por: Seif, Farhad, et al.
Publicado: (2023)

Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2013)

Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment
por: Zappasodi, Roberta, et al.
Publicado: (2014)

Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T cell responses during pulmonary viral infection
por: de Almeida Nagata, Denise E., et al.
Publicado: (2015)

Tumor microenvironment antigens
por: Andersen, Mads Hald
Publicado: (2022)

Blockade of surface bound TGF-β abrogates Treg suppression of effector T cell function within the tumor microenvironment
por: Budhu, Sadna, et al.
Publicado: (2014)

Targeting hyaluronan accumulation in the tumor microenvironment
por: Li, Xiaoming, et al.
Publicado: (2018)

Tumor microenvironment in NSCLC suppresses NK cells function
por: Cremer, Isabelle, et al.
Publicado: (2012)

Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients
por: Núñez, Nicolas Gonzalo, et al.
Publicado: (2020)

Aberrant accumulation of Dickkopf 4 promotes tumor progression via forming the immune suppressive microenvironment in gastrointestinal stromal tumor
por: Wang, Ming, et al.
Publicado: (2019)

Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?
por: Copsel, Sabrina N., et al.
Publicado: (2022)

Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumors
por: Hagar, Amit, et al.
Publicado: (2019)

Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
por: Laplagne, Chloé, et al.
Publicado: (2019)

Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
por: Xie, Ya-Jia, et al.
Publicado: (2023)

Tumor Progression, Microenvironments, and Therapeutics
por: Cheng, Hung-Chi, et al.
Publicado: (2022)

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy
por: Wakiyama, Hiroaki, et al.
Publicado: (2022)

Tregitopes Improve Asthma by Promoting Highly Suppressive and Antigen-Specific Tregs
por: Dembele, Marieme, et al.
Publicado: (2021)

Tn Antigen Expression Contributes to an Immune Suppressive Microenvironment and Drives Tumor Growth in Colorectal Cancer
por: Cornelissen, Lenneke A. M., et al.
Publicado: (2020)

Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity
por: Chen, Zilin, et al.
Publicado: (2021)

Advances in landscape and related therapeutic targets of the prostate tumor microenvironment: Therapeutic targets of the prostate tumor microenvironment
por: Li, Duocai, et al.
Publicado: (2023)

CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function
por: Whiteside, Sarah K., et al.
Publicado: (2021)

The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells
por: Sharma, Madhav, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ce71n1fkukb6v11bifk60a3rtt